NCT02620956 is a Phase 2 clinical trial of nebulizing with heliox and oxygen in Obese, sponsored by Jacqueline de Melo Barcelar.

Who is sponsoring NCT02620956?

NCT02620956 is sponsored by Jacqueline de Melo Barcelar.

What drugs are being tested in NCT02620956?

Interventions in NCT02620956: nebulizing with heliox and oxygen.

What condition does NCT02620956 study?

NCT02620956 studies Obese, Asthma.

Is NCT02620956 still recruiting?

NCT02620956 is currently completed. Last updated 14 September 2016.

Last reviewed 2016-09-14 · How we verify

NCT02620956

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aerosol Deposition in Asthmatic Obese Women Using Heliox: A Randomized, Crossover, Controlled Clinical Trial Study

Completed Phase 2 Last updated 14 September 2016

What this trial tests

Phase 2 trial testing nebulizing with heliox and oxygen in Obese in 20 participants. Completed in 1 January 2016.

Timeline

1 November 2015

Primary endpoint
1 December 2015

1 January 2016

Quick facts

Lead sponsor	Jacqueline de Melo Barcelar
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	1 November 2015
Primary completion	1 December 2015
Estimated completion	1 January 2016
Sites	1 location across Brazil

Drugs / interventions tested

nebulizing with heliox and oxygen

Conditions studied

Obese — all drugs for Obese →
Asthma — all drugs for Asthma →

Sponsor

Jacqueline de Melo Barcelar

Who can join

Adults 18 to 60, female only, with Obese or Asthma. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Aerosol deposition in pulmonary compartments
Time frame: two days

Sponsor's own description

BACKGROUND: The aim of this study was to assess pulmonary deposition and distribution of radio-aerosol in obese and normal women, using 2-D planar scintigraphy. METHODS: after inhaling an aerosol of technetium labeled diethylenetriamine penteacetic acid (99mTc - DTPA) with an activity of 1 mCi in a total dose volume with normal saline of 2,5 ml using a vibrating mesh inhaler.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Obese

Currently open trials in the same condition.

NCT07411560 — A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in Peopl · Phase 1 · recruiting
NCT06719466 — Diet Intervention on Obesity Related Complication · NA · active not recruiting
NCT06590584 — Validity and Reliability of the 6-minute Pegboard Ring Test in Obese Individuals · recruiting
NCT06562660 — The Effect of Mask Combined With High Flow Oxygen on Preoxygenation During Induction of General Anesthesia in Obese Pati · NA · recruiting
NCT05819853 — Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02620956 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jacqueline de Melo Barcelar
Last refreshed: 14 September 2016

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02620956.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing